Pre-hospital Rule-out of Acute Coronary Syndrome
- Conditions
- Acute Coronary Syndrome
- Interventions
- Diagnostic Test: Pre-hospital rule-out strategy
- Registration Number
- NCT05466591
- Lead Sponsor
- Radboud University Medical Center
- Brief Summary
Patients with chest pain suspected for non ST-segment elevation acute coronary syndrome (NSTE-ACS) are routinely transferred to the emergency department (ED). A point-of-care (POC) troponin measurement might enable ambulance paramedics to identify low-risk patients in whom ED evaluation is not necessary. The ARTICA trial aims to assess the healthcare cost reduction and safety of a pre-hospital rule-out strategy using a single POC troponin measurement.
- Detailed Description
Patients with chest pain suspected of a NSTE-ACS are screened by ambulance paramedics. The HEAR score (HEART score without the Troponin component) is assessed and patients with a HEAR score of ≤3 are included. The patients are randomised to 1) pre-hospital rule-out with POC troponin measurement (intervention group) and 2) direct transfer to the ED (standard care group). Primary outcome is healthcare costs after 30 days.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 866
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Pre-hospital rule-out strategy Pre-hospital rule-out strategy Patients undergo a point-of-care troponin T measurement. If troponin is low, an acute coronary syndrome is considered ruled-out and the care for the patient is transferred to the general practitioner. If troponin is elevated, the patient is immediately transported to the emergency department.
- Primary Outcome Measures
Name Time Method Costs from a healthcare perspective (all costs related to healthcare consumption in-hospital, all outpatient visits including diagnostic tests and general practitioner consultations) 30 days Healthcare costs consist of all costs related to healthcare consumption
- Secondary Outcome Measures
Name Time Method Safety: all cause death, acute coronary syndrome, unplanned revascularisation 30 days Major adverse cardiac events (all cause death, ACS, unplanned revascularisation)
Costs from a societal perspective (all health effects and changes in resource use caused by an intervention) 30 days Costs from a societal perspective are defined as the sum of the healthcare costs and the costs from productivity losses.
Safety (all cause death, acute coronary syndrome, unplanned revascularisation) 12 months Major adverse cardiac events (all cause death, ACS, unplanned revascularisation)
Trial Locations
- Locations (1)
RadboudUMC
🇳🇱Nijmegen, Netherlands